S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Europe bans Russian diesel, other oil products over Ukraine
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Biden's State of the Union to tout policy wins on economy
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
How will EU ban and West's price cap on Russian diesel work?
Evacuations urged in Ohio town as train wreck smolders
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
'Knock at the Cabin' knocks off 'Avatar' at the box office
LON:AVO

Advanced Oncotherapy - AVO Share Forecast, Price & News

GBX 9.75
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
9.50
10
50-Day Range
9.75
17.10
52-Week Range
9.50
32
Volume
501,943 shs
Average Volume
593,889 shs
Market Capitalization
£52.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AVO stock logo

About Advanced Oncotherapy (LON:AVO) Stock

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Advanced Oncotherapy raises £2mln at a premium
Advanced Oncotherapy plc (AVO.L)
Hardman & Co Research: Advanced Oncotherapy (AVO): On the home straight
Advanced Oncotherapy : Result of AGM
Advanced Oncotherapy says 2021 to be important year
Advanced Oncotherapy : Total Voting Rights
See More Headlines
Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Company Calendar

Last Earnings
6/29/2020
Today
2/05/2023

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
139
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.29 per share
Book Value
GBX 13.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£52.40 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Michael Jeffrey Sinclair (Age 79)
    Exec. Chairman
    Comp: $434.42k
  • Mr. Nicolas Serandour
    CEO & Exec. Director
  • Prof. Stephen Myers OBE (Age 75)
    Exec. Director
    Comp: $397.72k
  • Mr. Ed Lee
    COO & Pres of Europe
  • Mr. Graham Pughe
    Sr. Vice-Pres of Accounting
  • Ms. Berengere Pons-Chabord
    Sr. Vice-Pres of Corp. Fin.
  • Dr. Manuel Gallas
    Director of Technical & Engineering
  • Mr. David Navas
    VP of Investor and PR
  • Ms. Bridget Biggar
    Director of HR
  • Ms. Donatella Ungaro
    Managing Director of ADAM













AVO Stock - Frequently Asked Questions

How have AVO shares performed in 2023?

Advanced Oncotherapy's stock was trading at GBX 13.50 at the beginning of the year. Since then, AVO shares have decreased by 27.8% and is now trading at GBX 9.75.
View the best growth stocks for 2023 here
.

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) released its earnings results on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).

What is Advanced Oncotherapy's stock symbol?

Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Advanced Oncotherapy's stock price today?

One share of AVO stock can currently be purchased for approximately GBX 9.75.

How much money does Advanced Oncotherapy make?

Advanced Oncotherapy (LON:AVO) has a market capitalization of £52.40 million.

How many employees does Advanced Oncotherapy have?

The company employs 139 workers across the globe.

How can I contact Advanced Oncotherapy?

Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The official website for the company is www.advancedoncotherapy.com. The company can be reached via phone at +44-20-36178728.

This page (LON:AVO) was last updated on 2/5/2023 by MarketBeat.com Staff